Indications and Usage for Indocin Injection
INDOCIN I.V. is indicated to close a
hemodynamically significant patent ductus arteriosus in
premature infants weighing between 500 and 1750 g when after 48
hours usual medical management (e.g., fluid restriction,
diuretics, digitalis, respiratory support, etc.) is ineffective.
Clear-cut clinical evidence of a hemodynamically significant
patent ductus arteriosus should be present, such as respiratory
distress, a continuous murmur, a hyperactive precordium,
cardiomegaly and pulmonary plethora on chest x-ray.
Read more:
http://www.drugs.com/pro/indocin-injection.html#ixzz0reevPwNi
Indications and Usage for Indocin Injection
INDOCIN I.V. is indicated to close a
hemodynamically significant patent ductus arteriosus in
premature infants weighing between 500 and 1750 g when after 48
hours usual medical management (e.g., fluid restriction,
diuretics, digitalis, respiratory support, etc.) is ineffective.
Clear-cut clinical evidence of a hemodynamically significant
patent ductus arteriosus should be present, such as respiratory
distress, a continuous murmur, a hyperactive precordium,
cardiomegaly and pulmonary plethora on chest x-ray.
Read more:
http://www.drugs.com/pro/indocin-injection.html#ixzz0reevPwNi
Indications and Usage for Indocin Injection
INDOCIN I.V. is indicated to close a
hemodynamically significant patent ductus arteriosus in
premature infants weighing between 500 and 1750 g when after 48
hours usual medical management (e.g., fluid restriction,
diuretics, digitalis, respiratory support, etc.) is ineffective.
Clear-cut clinical evidence of a hemodynamically significant
patent ductus arteriosus should be present, such as respiratory
distress, a continuous murmur, a hyperactive precordium,
cardiomegaly and pulmonary plethora on chest x-ray.
Read more:
http://www.drugs.com/pro/indocin-injection.html#ixzz0reevPwNi
Indications and Usage for Indomethacin
Injection:
Indomethacin for Injection is indicated to close a
hemodynamically significant patent ductus arteriosus in premature infants
weighing between 500 and 1750 g when after 48 hours usual medical management
(e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is
ineffective. Clear-cut clinical evidence of a hemodynamically significant patent
ductus arteriosus should be present, such as respiratory distress, a continuous
murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest
x-ray.
Learn more about Indomethacin for Injection at:
http://www.bedfordlabs.com/BedfordLabsWeb/products/inserts/INDO-P01.PDF
